aTyr Pharma, Inc.
ATYR
$4.06
$0.0651.63%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -52.20% | -32.16% | -29.62% | -96.25% | 14.38% |
| Total Depreciation and Amortization | -60.93% | -34.64% | 1.99% | -41.61% | 139.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 144.76% | 96.68% | -133.67% | -139.72% | -142.63% |
| Change in Net Operating Assets | 223.84% | -26,476.47% | -172.95% | 185.43% | 680.53% |
| Cash from Operations | -37.65% | -70.27% | -3,693.22% | -6.68% | 22.16% |
| Capital Expenditure | 97.31% | 99.67% | 98.64% | 98.48% | -30.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 263.58% | 479.28% | 96.37% | 472.00% | -76.55% |
| Cash from Investing | 309.45% | 261.89% | 96.45% | 791.35% | -78.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -15.74% | -17.14% | -83.33% | -74.24% | -- |
| Issuance of Common Stock | -99.28% | 66.48% | -84.16% | 540.52% | -8.13% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -103.91% | 67.12% | -84.38% | 557.30% | -10.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 287.77% | 96.06% | -249.11% | 271.63% | -121.91% |
